Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Lupus|October 13, 2005
New trends in anticoagulant treatmentsV Pengo
Journal of Thrombosis and Haemostasis : JTH|April 1, 2008
A contribution to the debate on the laboratory criteria that define the antiphospholipid syndromeV Pengo
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
Antithrombotic strategies for atrial fibrillation: on the threshold of changes? NoV Pengo
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillation?V Pengo
Comprehensive Therapy|April 3, 2001
Oral anticoagulant treatment in very elderly patients with atrial fibrillationV Pengo
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Anti-beta2-glycoprotein I antibody testing in the laboratory diagnosis of antiphospholipid syndromeV Pengo
Thrombosis Research|October 3, 2012
ISTH guidelines on lupus anticoagulant testingV Pengo
Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Antiphospholipid syndrome: interpretation of laboratory dataV Pengo
Haematologica|January 5, 2002
[Thromboembolism in non-rheumatic atrial fibrillation]V Pengo
Journal of Thrombosis and Haemostasis : JTH|September 18, 2016
Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: commentV Pengo
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Lupus|October 13, 2005
New trends in anticoagulant treatmentsV Pengo
Journal of Thrombosis and Haemostasis : JTH|April 1, 2008
A contribution to the debate on the laboratory criteria that define the antiphospholipid syndromeV Pengo
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
Antithrombotic strategies for atrial fibrillation: on the threshold of changes? NoV Pengo
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Long-term warfarin use to prevent both stroke and dementia in subjects with atrial fibrillation?V Pengo
Comprehensive Therapy|April 3, 2001
Oral anticoagulant treatment in very elderly patients with atrial fibrillationV Pengo
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Anti-beta2-glycoprotein I antibody testing in the laboratory diagnosis of antiphospholipid syndromeV Pengo
Thrombosis Research|October 3, 2012
ISTH guidelines on lupus anticoagulant testingV Pengo
Journal of Thrombosis and Haemostasis : JTH|December 1, 2010
Antiphospholipid syndrome: interpretation of laboratory dataV Pengo
Haematologica|January 5, 2002
[Thromboembolism in non-rheumatic atrial fibrillation]V Pengo
Journal of Thrombosis and Haemostasis : JTH|September 18, 2016
Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: commentV Pengo
Pageof 17